ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $2.08M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
5
Closed
2
Calls
$3.83M
Puts
$2.3M
Net Calls
+$1.54M
Net Calls Change
-$3.31M
Top Buyers
| 1 |
VF
1
Virtu Financial
New York
|
$1.31M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$33K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $1.31M | +$291K | +4,498 | +29% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $354K | -$489K | -7,561 | -58% |
|
3
Morgan Stanley
New York
| $181K | -$167K | -2,574 | -48% |
|
4
Simplex Trading
Chicago,
Illinois
| $175K | -$181K | -2,811 | -51% |
|
|
5
UBS Group
Zurich,
Switzerland
| $33K | +$33K | +505 | New |
|
|
CG
6
Cutler Group
San Francisco,
California
| $29K | -$32.2K | -500 | -53% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1K | -$110K | -2,411 | -99% |
|
8
Jane Street
New York
| – | -$769K | -10,608 | Closed |
|
9
Goldman Sachs
New York
| – | -$316K | -4,367 | Closed |
|